As Metlife Inc (NYSE:MET) Price Declined, Shareholder Epoch Investment Partners Inc Upped Its Position

May 17, 2018 - By Robert Shackelford

MetLife, Inc. (NYSE:MET) Corporate LogoDuring Q4 2017 the big money sentiment increased to 1.02. That’s change of 0.13, from 2017Q3’s 0.89. 45 investors sold all, 330 reduced holdings as MET ratio is positive. 290 rose stakes while 93 funds bought stakes. Funds hold 782.94 million shares thus 0.24% less from 2017Q3’s 784.85 million shares. Brown Advisory Securities Ltd Liability Corp reported 41,249 shs stake. Agf Investments Inc holds 1.27 million shs. Menora Mivtachim Hldgs Ltd accumulated 373,600 shs. 125,497 were accumulated by Gw Henssler Assocs Ltd. Everence Management holds 24,023 shs or 0.27% of its capital. Next Grp holds 5,521 shs or 0.12% of its capital. Nelson Roberts Advsrs Limited Liability Com invested 0.01% in MetLife, Inc. (NYSE:MET). 38,000 are owned by Oakbrook Invests Ltd Liability Corporation. Calamos Wealth Ltd Co holds 0.61% or 92,829 shs in its capital. Griffin Asset Management reported 0.74% of its capital in MetLife, Inc. (NYSE:MET). Regentatlantic Cap Lc invested in 123,146 shs. Moreover, First Eagle Mgmt Ltd Liability has 0% invested in MetLife, Inc. (NYSE:MET). Aldebaran Financial Incorporated reported 34,721 shs or 1.17% of all its holdings. 51,875 are held by Arga Mgmt Lp. Moreover, Valley Advisers has 0.03% invested in MetLife, Inc. (NYSE:MET).

The holdings In Metlife Inc (NYSE:MET) owned by Epoch Investment Partners Inc was increased. According to 2018Q1 Securities and Exchange regulatory report the rise is 10.74%. Metlife Inc (NYSE:MET) declined 10.38% with the market as Epoch Investment Partners Inc bought 1.14M shares. Epoch Investment Partners Inc announced $537.64M position in Epoch Investment Partners Inc for 2018Q1. Now it holds 11.72M shares, compared to 10.58M last quarter. $48.68 billion is the Metlife Inc’s market cap. MET hit $47.89 during the last trading session after $0.41 change.MetLife, Inc. has volume of 3.78 million shares. Since May 17, 2017 MET has declined 1.24% and is downtrending. MET underperformed by 12.79% the S&P500.

$43.62B and $28.22 billion US longs are managed by Epoch Investment Partners Inc. According to Securities and Exchange [filling] the stake in Astrazeneca Plc (NYSE:AZN) was reduced by 352,353 shares to 8.66 million shares. They are valued at $303.00M in 2018Q1. Epoch Investment Partners Inc cut its stake in Entergy Corp New (NYSE:ETR) and reduced Reliance Steel & Aluminum Co (NYSE:RS) position by 178,581 shares for a total of 466,458 shares.

Epoch Investment Partners Inc is a New York-based institutional investor with more than $43.62 billion AUM in January, 2015. Epoch Investment Partners Inc is the 100th largest institutional investor in our database. Taken from Epoch Investment Partners latest Adv, the fund reported to have 92 full and part-time employees. Among which 35 performing investment advisory and research functions. The institutional investor had more than 1800 clients.

MetLife, Inc. (NYSE:MET) Ratings Coverage

In total 9 analysts cover Metlife (NYSE:MET). “Buy” rating has 4, “Sell” are 0, while 5 are “Hold”. (NYSE:MET) has 44% bullish analysts. 13 are the (NYSE:MET)’s ratings reports on 17 May 2018 according to StockzIntelligence Inc. The stock rating was maintained by Morgan Stanley with “Equal-Weight” on Wednesday, February 14. On Tuesday, January 30 the rating was maintained by Wells Fargo with “Outperform”. On Friday, May 4 Deutsche Bank maintained MetLife, Inc. (NYSE:MET) with “Hold” rating. On Wednesday, April 11 Keefe Bruyette & Woods maintained MetLife, Inc. (NYSE:MET) rating. Keefe Bruyette & Woods has “Buy” rating and $5500 target. On Thursday, April 5 the firm earned “Hold” rating by Sandler O’Neill. On Thursday, March 15 the rating was maintained by Wells Fargo with “Buy”. On Monday, March 26 the stock of MetLife, Inc. (NYSE:MET) earned “Overweight” rating by Atlantic Securities. On Thursday, April 5 the firm has “Equal-Weight” rating given by Morgan Stanley. On Monday, March 26 the rating was initiated by Bank of America with “Hold”. On Thursday, December 21 the firm earned “Buy” rating by Keefe Bruyette & Woods.

MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East.The company has $48.68 billion market cap. It operates in six divisions: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; MetLife Holdings; and Brighthouse Financial.13.24 is the P/E ratio. The firm offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, and critical illness insurance products; vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only and private floating rate funding agreements; and account guaranteed, separate account guaranteed, and trust guaranteed interest contracts.

MetLife, Inc. (NYSE:MET) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: